Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: September 2020
Date Filed: September 9, 2020
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
This filing serves as a company update regarding the Annual Report 2020. The registrant files annual reports under Form 20-F.
Key Financial Metrics
The provided filing text does not contain specific financial data. No values are reported for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing text does not provide details on material changes versus prior comparable periods. It references an update on the Annual Report 2020 but does not include the comparative financial figures within this specific Form 6-K text.
Guidance, Outlook, and Risks
Management Commentary: The filing is signed by Geoffrey Kempler, Executive Chairman, indicating a company update on the 2020 Annual Report.
Registration Statements: This Form 6-K is incorporated by reference into Registration Statement on Form S-8 (File No. 333-228671) and Registration Statements on Form F-3 (Files No. 333-220886 and 333-231417).
Risks and Contingencies: The filing text does not explicitly list risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the full content of the referenced "Annual Report 2020" for detailed financial performance.
- Review the incorporated Registration Statements (Form S-8 and Form F-3) for details on capital raising or equity plans.
- Confirm the company's operational status and pipeline updates not detailed in this summary filing.